{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:37:49Z","timestamp":1772120269292,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009612","name":"Oregon State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000937","name":"M. J. Murdock Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bmc.2019.06.044","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:20:57Z","timestamp":1561681257000},"page":"3595-3604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Biological evaluation of molecules of the azaBINOL class as antiviral agents: Inhibition of HIV-1 RNase H activity by 7-isopropoxy-8-(naphth-1-yl)quinoline"],"prefix":"10.1016","volume":"27","author":[{"given":"Ross D.","family":"Overacker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somdev","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George F.","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selena","family":"Milicevic Sephton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Strother","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Brack-Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Blakemore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Loesgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2019.06.044_b0005","unstructured":"HIV\/AIDS factsheet; World Health Organization: http:\/\/www.who.int\/mediacentre\/factsheets\/fs360\/en\/ 2018."},{"key":"10.1016\/j.bmc.2019.06.044_b0010","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/jama.2017.13505","article-title":"An HIV vaccine is essential for ending the HIV\/AIDS pandemic","volume":"318","author":"Fauci","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.bmc.2019.06.044_b0015","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1097\/QAD.0000000000000494","article-title":"Global burden of transmitted HIV drug resistance and HIV-exposure categories: a systematic review and meta-analysis","volume":"28","author":"Pham","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.bmc.2019.06.044_b0020","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11633630-000000000-00000","article-title":"HIV-1 antiretroviral resistance","volume":"72","author":"Tang","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2019.06.044_b0025","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s40265-018-0993-4","article-title":"Doravirine: first global approval","volume":"78","author":"Deeks","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2019.06.044_b0030","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.4155\/fmc.13.178","article-title":"Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase","volume":"5","author":"Corona","year":"2013","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0035","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.2174\/0929867324666170113110839","article-title":"Update on recent developments in small molecular HIV-1 RNase H inhibitors (2013\u20132016): opportunities and challenges","volume":"25","author":"Wang","year":"2018","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2009.09.008","article-title":"Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989\u20132009)","volume":"85","author":"de B\u00e9thune","year":"2010","journal-title":"Antivir Res"},{"key":"10.1016\/j.bmc.2019.06.044_b0045","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/v2040900","article-title":"HIV-1 ribonuclease H: structure, catalytic mechanism and inhibitors","volume":"2","author":"Beilhartz","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.bmc.2019.06.044_b0050","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/cr040079g","article-title":"BINOL: a versatile chiral reagent","volume":"105","author":"Brunel","year":"2005","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2019.06.044_b0055","doi-asserted-by":"crossref","first-page":"8286","DOI":"10.1002\/anie.201401075","article-title":"The biocatalytic repertoire of natural biaryl formation","volume":"53","author":"Aldemir","year":"2014","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bmc.2019.06.044_b0060","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/cr100155e","article-title":"Atroposelective total synthesis of axially chiral biaryl natural products","volume":"111","author":"Bringmann","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2019.06.044_b0065","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1021\/jm00038a003","article-title":"Anti-HIV michellamines from Ancistrocladus korupensis","volume":"37","author":"Boyd","year":"1994","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1021\/np9700679","article-title":"Michellamines D\u2013F, new HIV-inhibitory dimeric naphthylisoquinoline alkaloids, and korupensamine E, a new antimalarial monomer, from Ancistrocladus korupensis","volume":"60","author":"Hallock","year":"1997","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.06.044_b0075","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1021\/jm00116a011","article-title":"Novel alkaloids from the tropical plant Ancistrocladus abbreviatus inhibit cell killing by HIV-1 and HIV-2","volume":"34","author":"Manfredi","year":"1991","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.phytochem.2016.04.005","article-title":"HIV-inhibitory michellamine-type dimeric naphthylisoquinoline alkaloids from the Central African liana Ancistrocladus congolensis","volume":"128","author":"Bringmann","year":"2016","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bmc.2019.06.044_b0085","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/AAC.39.2.484","article-title":"Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms","volume":"39","author":"McMahon","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.06.044_b0090","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/np960707s","article-title":"Diconcophylline A as a growth-retarding agent against the herbivorous insect Spodoptera littoralis: structure-activity relationships","volume":"60","author":"Bringmann","year":"1997","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.06.044_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015874","article-title":"Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol","volume":"6","author":"Teissier","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2019.06.044_b0100","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1021\/bi400166b","article-title":"A model of peptide triazole entry inhibitor binding to HIV-1 gp120 and the mechanism of bridging sheet disruption","volume":"52","author":"Emileh","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2019.06.044_b0105","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1073\/pnas.0909587107","article-title":"A broad-spectrum antiviral targeting entry of enveloped viruses","volume":"107","author":"Wolf","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2019.06.044_b0110","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/cb600303y","article-title":"HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site","volume":"1","author":"Himmel","year":"2006","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2019.06.044_b0115","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1021\/acs.jmedchem.6b00465","article-title":"Design, synthesis, and biological evaluations of hydroxypyridonecarboxylic acids as inhibitors of HIV reverse transcriptase associated RNase H","volume":"59","author":"Kankanala","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0120","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1055\/s-0035-1560640","article-title":"Synthesis, properties, and enantiomerization behavior of axially chiral phenolic derivatives of 8-(naphth-1-yl)quinoline and comparison to 7,7\u2019-dihydroxy-8,8'-biquinolyl and 1,1\u2019-bi-2-naphthol","volume":"47","author":"Banerjee","year":"2015","journal-title":"Synthesis"},{"key":"10.1016\/j.bmc.2019.06.044_b0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/jo048258l","article-title":"Harnessing anionic rearrangements on the benzenoid ring of quinoline for the synthesis of 6,6\u2019-disubstituted 7,7\u2019-dihydroxy-8,8'-biquinolyls","volume":"70","author":"Blakemore","year":"2005","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0130","doi-asserted-by":"crossref","first-page":"9368","DOI":"10.1021\/jo701611u","article-title":"Enzymatic resolution of 7,7'-dihydroxy-8,8'-biquinolyl dipentanoate and its conversion to 2,2'-Di-tert-butyl-7,7'-dihydroxy-8,8'-biquinolyl","volume":"72","author":"Blakemore","year":"2007","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0135","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1021\/ol201539d","article-title":"Synthesis of 7,7\u2019-dihydroxy-8,8'-biquinolyl (azaBINOL) via Pd-catalyzed directed double C-H functionalization of 8,8\u2019-biquinolyl: emergence of an atropos from a tropos state","volume":"13","author":"Wang","year":"2011","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2019.06.044_b0140","doi-asserted-by":"crossref","first-page":"8212","DOI":"10.1021\/jo061608e","article-title":"Resolution, enantiomerization kinetics, and chiroptical properties of 7,7\u2019-dihydroxy-8,8'-biquinolyl","volume":"71","author":"Blakemore","year":"2006","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0145","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1055\/s-2008-1078448","article-title":"Determination of pKa values for diether derivatives of 7,7'-dihydroxy-8,8'-biquinolyl: dependence of basicity on interannular dihedral angle","volume":"14","author":"Blakemore","year":"2008","journal-title":"Synthesis"},{"key":"10.1016\/j.bmc.2019.06.044_b0150","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1002\/ejoc.201200333","article-title":"Silylcyanation of aldehydes, ketones, and imines catalyzed by a 6,6\u2019-bis-sulfonamide derivative of 7,7\u2019-dihydroxy-8,8'-biquin-olyl (azaBINOL)","volume":"2012","author":"Sephton","year":"2012","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0155","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1055\/s-0033-1340519","article-title":"Enantioselective synthesis of biaryl compounds via Suzuki-Miyaura cross-coupling using a palladium complex of 7'-butoxy-7-(diphenylphosphino)-8,8'-biquinolyl: investigation of a new chiral ligand architecture","volume":"46","author":"Wu","year":"2014","journal-title":"Synthesis"},{"key":"10.1016\/j.bmc.2019.06.044_b0160","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1128\/JVI.00709-09","article-title":"Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1","volume":"83","author":"Platt","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2019.06.044_b0165","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","article-title":"Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1","volume":"72","author":"Platt","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2019.06.044_b0170","doi-asserted-by":"crossref","first-page":"12585","DOI":"10.1128\/JVI.01726-08","article-title":"Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research","volume":"82","author":"Takeuchi","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2019.06.044_b0175","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.06.044_b0180","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1128\/JVI.74.18.8358-8367.2000","article-title":"Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120","volume":"74","author":"Derdeyn","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2019.06.044_b0185","series-title":"Methods in enzymology","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0076-6879(95)62015-X","article-title":"Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase","author":"Le Grice","year":"1995"},{"key":"10.1016\/j.bmc.2019.06.044_b0190","article-title":"Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays","volume":"64","author":"Montefiori","year":"2005","journal-title":"Curr Protoc Immnol"},{"key":"10.1016\/j.bmc.2019.06.044_b0195","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1128\/AAC.00515-10","article-title":"EASY-HIT: HIV full-replication technology for broad discovery of multiple classes of HIV inhibitors","volume":"54","author":"Kremb","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.06.044_b0200","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0042-6822(91)90537-L","article-title":"Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI","volume":"185","author":"Peden","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.bmc.2019.06.044_b0205","doi-asserted-by":"crossref","first-page":"20394","DOI":"10.1038\/srep20394","article-title":"Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins","volume":"6","author":"Rebensburg","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2019.06.044_b0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.bmc.2019.06.044_b0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ab.2003.06.001","article-title":"A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity","volume":"322","author":"Parniak","year":"2003","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmc.2019.06.044_b0220","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/abio.1993.1355","article-title":"Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods","volume":"212","author":"Oshannessy","year":"1993","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmc.2019.06.044_b0225","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1039\/C7MD00600D","article-title":"Structure-guided approach identifies a novel class of HIV-1 ribonuclease H inhibitors: binding mode insights through magnesium complexation and site-directed mutagenesis studies","volume":"9","author":"Poongavanam","year":"2018","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmc.2019.06.044_b0230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jphotobiol.2011.11.008","article-title":"Luciferase inhibition by a novel naphthoquinone","volume":"107","author":"Bedford","year":"2012","journal-title":"J Photochem Photobiol"},{"key":"10.1016\/j.bmc.2019.06.044_b0235","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1021\/jm400535b","article-title":"Compound aggregation in drug discovery: implementing a practical NMR assay for medicinal chemists","volume":"56","author":"LaPlante","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0240","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.bmc.2016.02.044","article-title":"Design and synthesis of small molecule-sulfotyrosine mimetics that inhibit HIV-1 entry","volume":"24","author":"Dogo-Isonagie","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0245","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1021\/jm800245z","article-title":"Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection","volume":"51","author":"Summa","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0250","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/acs.jnatprod.5b00947","article-title":"Feeling nature\u2019s PAINS: Natural products, natural product drugs, and pan assay interference compounds (PAINS)","volume":"79","author":"Baell","year":"2016","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2019.06.044_b0255","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1021\/jm701302v","article-title":"Characterization of chemical libraries for luciferase inhibitory activity","volume":"51","author":"Auld","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0260","article-title":"RNase H polymerase-independent cleavage assay for evaluation of RNase H activity of reverse transcriptase enzymes","volume":"5","author":"Corona","year":"2015","journal-title":"Bio Protoc"},{"key":"10.1016\/j.bmc.2019.06.044_b0265","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1128\/AAC.00434-10","article-title":"Structure-activity analysis of vinylogous urea inhibitors of human immunodeficiency virus-encoded ribonuclease H","volume":"54","author":"Chung","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.06.044_b0270","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/cb8001039","article-title":"Vinylogous ureas as a novel class of inhibitors of reverse transcriptase-associated ribonuclease H activity","volume":"3","author":"Wendeler","year":"2008","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2019.06.044_b0275","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/cmdc.201600015","article-title":"Studies on cycloheptathiophene-3-carboxamide derivatives as allosteric HIV-1 ribonuclease H inhibitors","volume":"11","author":"Corona","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2019.06.044_b0280","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1128\/AAC.06000-11","article-title":"Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase","volume":"56","author":"Kirby","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2019.06.044_b0285","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/nar\/gki268","article-title":"Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones","volume":"33","author":"Budihas","year":"2005","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.bmc.2019.06.044_b0290","doi-asserted-by":"crossref","first-page":"16270","DOI":"10.1074\/jbc.M114.569707","article-title":"Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociation","volume":"289","author":"Beilhartz","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0295","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1021\/acs.jmedchem.7b00440","article-title":"Double-winged 3-hydroxypyrimidine-2, 4-diones: potent and selective inhibition against HIV-1 RNase H with significant antiviral activity","volume":"60","author":"Vernekar","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0300","doi-asserted-by":"crossref","first-page":"02203","DOI":"10.1128\/JVI.02203-17","article-title":"Developing and evaluating inhibitors against the RNase H active site of HIV-1 RT","volume":"92","author":"Boyer","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2019.06.044_b0305","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1093\/nar\/gkg881","article-title":"Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors","volume":"31","author":"Klumpp","year":"2003","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.bmc.2019.06.044_b0310","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejmech.2019.01.081","article-title":"Pharmacophore-based design of novel 3-hydroxypyrimidine-2, 4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: Tolerance of a nonflexible linker","volume":"166","author":"Tang","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0315","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejmech.2018.06.036","article-title":"5-Hydroxypyrido [2, 3-b] pyrazin-6 (5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase","volume":"155","author":"Sun","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0320","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/cbdd.13455","article-title":"Design, synthesis, and biologic evaluation of novel galloyl derivatives as HIV-1 RNase H inhibitors","volume":"93","author":"Gao","year":"2019","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2019.06.044_b0325","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2004.11.002","article-title":"6-[1-(4-Fluorophenyl) methyl-1H-pyrrol-2-yl)]-2, 4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro","volume":"65","author":"Tramontano","year":"2005","journal-title":"Antivir Res"},{"key":"10.1016\/j.bmc.2019.06.044_b0330","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14756366.2018.1523901","article-title":"From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors","volume":"34","author":"Massari","year":"2019","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0335","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1021\/jm400405z","article-title":"Exploiting drug-resistant enzymes as tools to identify thienopyrimidinone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H","volume":"56","author":"Masaoka","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0340","doi-asserted-by":"crossref","DOI":"10.3791\/51383-v","article-title":"Bio-layer interferometry for measuring kinetics of protein-protein interactions and allosteric ligand effects","author":"Shah","year":"2014","journal-title":"J Vis Exp"},{"key":"10.1016\/j.bmc.2019.06.044_b0345","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody","volume":"393","author":"Kwong","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2019.06.044_b0350","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid evolution of the neutralizing antibody response to HIV type 1 infection","volume":"100","author":"Richman","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2019.06.044_b0355","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nri3516","article-title":"Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning","volume":"13","author":"Kwong","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bmc.2019.06.044_b0360","article-title":"Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2019.06.044_b0365","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1124\/mol.62.2.398","article-title":"Destabilization of the HIV-1 reverse transcriptase dimer upon interaction with N-acyl hydrazone inhibitors","volume":"62","author":"Sluis-Cremer","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmc.2019.06.044_b0370","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/jm501132s","article-title":"Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1, 3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities","volume":"58","author":"Vernekar","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.06.044_b0375","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bbrc.2006.11.018","article-title":"Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs)","volume":"352","author":"Hang","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2019.06.044_b0380","first-page":"1","article-title":"Biaryls in nature: a multi-facetted class of stereochemically, biosynthetically, and pharmacologically intriguing secondary metabolites","volume":"82","author":"Bringmann","year":"2001","journal-title":"Prog Chem Org Nat Prod"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619306704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619306704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:03:50Z","timestamp":1760835830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619306704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":76,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0968089619306704"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.06.044","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/525105","asserted-by":"object"}]},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological evaluation of molecules of the azaBINOL class as antiviral agents: Inhibition of HIV-1 RNase H activity by 7-isopropoxy-8-(naphth-1-yl)quinoline","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.06.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}